The Next Generation of
Branched Endografts

Through its patented technologies, Red Vascular’s branched endograft system represents a significant leap forward in minimally invasive treatment of complex aortic aneurysms, involving the take-offs of major arterial branches.  


Red Vascular Technology’s founders are Myles Douglas, MD, PhD, and James W. Hill, MD, JD. They represent more than fifty years of experience in clinical medicine, surgery, medical device design, and intellectual property.
Dr. Douglas was a founder and the lead inventor of the Endologix aneurysm treatment system. His disruptive technologies, along with his intimate working experience in design and construction of vascular endografts while at Arizona Heart Institute, allowed Endologix to progress from concept to commercial product in less than two years, saving patients’ lives and generating significant revenue.